Birmingham

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)1 trial
• Coronary artery disease1 trial
• Sarcoidosis1 trial
• Stroke1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals3 trials

Running trials

• Recruiting

  Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  NCT06947993· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)1 recruiting

Closed trials

• Completed

  Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis

  NCT04064242· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

  NCT04023552· Phase 3· Novartis Pharmaceuticals· Source